Mice harboring the NLRC4 T337S mutation exhibit elevated serum IL-18 and canonical inflammasome activation (via Pycard, Casp1, and Gsdmd) in IECs but fail to develop spontaneous colitis or systemic inflammation, even upon immune challenge [19, 20]. Here, NLRC4 is linked to colitis.